Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis
详细信息 查看全文
- 作者：Silvia Martini ; Marco Sacco ; Silvia Strona ; Daniele Arese ; Francesco Tandoi ; Dominic Dell Olio ; Davide Stradella ; Donatella Cocchis ; Stefano Mirabella ; Giorgia Rizza ; Paola Magistroni ; Pamela Moschini ; Antonio Ottobrelli ; Antonio Amoroso ; Mario Rizzetto ; Mauro Salizzoni ; Giorgio M. Saracco and Renato Romagnoli
- 刊名：Liver International
- 出版年：2017
- 出版时间：January 2017
- 年：2017
- 卷：37
- 期：1
- 页码：62-70
- 全文大小：483K
- ISSN：1478-3231
文摘
Several studies have shown that new direct-acting antivirals maintain their efficacy in liver transplant (LT) recipients with severe hepatitis C virus (HCV) recurrence. We determined the clinical impact of sofosbuvir/ribavirin in LT through the changes in liver function and fibrosis state at 24 and 48 weeks after treatment.